Free Trial

NextCure (NXTC) SEC Filings & 10K Form

NextCure logo
$6.81 +0.09 (+1.34%)
Closing price 10/15/2025 03:59 PM Eastern
Extended Trading
$6.80 -0.01 (-0.16%)
As of 08:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NextCure SEC Filings

DateFilerForm TypeView
09/29/2025
3:00 PM
Hainan Simcere Zaiming Pharmaceutical Co., Ltd. (Reporting)
Jiangsu Simcere Zaiming Pharmaceutical Co., Ltd. (Reporting)
NextCure (Issuer)
Ren Jinsheng (Reporting)
Simcere Pharmaceutical Group Ltd (Reporting)
Simcere Zaiming, Inc. (Reporting)
Tang Renhong (Reporting)
Form 3/A
08/25/2025
3:11 PM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2025
8:46 PM
NextCure (Subject)
Simcere Zaiming, Inc. (Filed by)
Form SCHEDULE 13G
08/19/2025
8:32 PM
NextCure (Issuer)
Simcere Zaiming, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/29/2025
11:15 PM
NextCure (Filer)
Form EFFECT
07/14/2025
6:15 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
8:00 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
3:30 PM
Feigal Ellen (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:30 PM
NextCure (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:30 PM
Borgman Anne Elizabeth (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:31 PM
KABAKOFF DAVID S (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:31 PM
Jones Elaine V (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:31 PM
Houston John G (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
8:15 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
6:15 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
3:20 PM
NextCure (Filer)
Form DEFA14A
05/19/2025
3:22 PM
NextCure (Filer)
Form DEFA14A
05/12/2025
11:54 AM
CITIGROUP INC (Filed by)
CITIGROUP INC (Filed by)
NextCure (Subject)
Form SCHEDULE 13G
05/01/2025
3:25 PM
NextCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
3:15 PM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
5:04 AM
NextCure (Filer)
Form DEF 14A
04/25/2025
5:08 AM
NextCure (Filer)
Form DEFA14A
04/10/2025
7:30 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
12:40 PM
Logos Global Management LP (Filed by)
NextCure (Subject)
Form SCHEDULE 13G/A
02/03/2025
5:22 PM
NextCure (Issuer)
Richman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:22 PM
Cobourn Steven P. (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:22 PM
Kundu Sourav (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:22 PM
Langermann Sol (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:22 PM
Mayer Timothy (Reporting)
NextCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:23 PM
NextCure (Issuer)
Shaw Kevin G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:10 PM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:15 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
7:10 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
6:11 AM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:59 PM
Logos Global Management LP (Filed by)
NextCure (Subject)
Form SC 13G/A
11/13/2024
3:06 PM
Affinity Asset Advisors, LLC (Filed by)
NextCure (Subject)
Form SC 13G/A
11/08/2024
3:15 PM
NextCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NXTC) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners